Innate Pharma S.A. (IPHA)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
1.75
-0.03 (-1.69%)
At close: Jan 15, 2025, 9:48 AM
Innate Pharma S.A. Forecast
Stock Price Forecast
The 1 analysts with 12-month price forecasts for IPHA stock have an median target of 11.5, with a low estimate of 11.5 and a high estimate of 11.5. The median target predicts an increase of 557.14% from the current stock price of 1.75.
Analyst Consensus: Buy
AI Analyst Report
HC Wainwright & Co. maintains a Buy rating on Inna... Unlock content with Pro Subscription
Updated Dec 09, 2024
Financial Forecast this Year
Revenue This Year
45.77M
from 51.90M
Increased by -11.8%
Revenue Next Year
95.82M
from 45.77M
Increased by 109.3%
EPS This Year
-0.31
from -0.09
Increased by -244.4%
EPS Next Year
0.17
from -0.31
Increased by 45.2%